10/09/20 NOTICE: PLEASE READ OUR MEMO REGARDING OUR EMPLOYEE SAFETY PROTOCOLS August 26, 2020 - CMS has issued CMS-3401-IFC, "Additional Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency related to Long-Term Care (LTC) Facility Testing Requirements and Revised COVID-19 Focused Survey Tool", expanding standards that LTCs must follow to prevent

April 7, 2020 - Aculabs will immediately begin performing COVID-19 screenings via the BioGX SARS-CoV-2 Reagents for BD MAX™ System, a real-time RT-PCR test intended for the qualitative detection of nucleic acid from SARS-CoV-2. The ability to perform screenings will allow for result reporting within 24 hours, vital to the high-risk populations Aculabs services as

4/7/20: Aculabs now offers SARS-CoV-2 testing for COVID-19 - Read More The New Jersey Department of Health has announced, starting on February 28, 2020, that the CDC SARS-CoV-2 real-time RT-PCR test will now be available at New Jersey Public Health and Environmental Laboratories. For the convenience of client facilities, Aculabs will participate in shipping the

Above: The CPP diplomates pose at the CPOCT Division & Awards Meeting, Tuesday, August 6, 2019, at the 2019 American Association for Clinical Chemistry (AACC) Annual Scientific Meeting & Clinical Lab Expo (Anaheim, CA); Dr. Rita Khoury, Aculabs' Lab Director, stands in the center. Photo courtesy of Medical Lab Observer. In August 2019,

Aculabs is pleased to announce our newest offering; a molecular diagnostic test for the direct qualitative detection and differentiation of enteric pathogens performed on the BD MAXTM Molecular system. Acute Gastroenteritis affects 1 in 6 Americans, causing approximately 179 million outpatient visits, 500,000 hospitalizations and >5,000 deaths each year.  Pathogens causing Infectious Gastroenteritis are primarily

The Centers for Disease Control and Prevention have issued new recommendations for TB Testing in the expectation that ongoing shortages will continue until the new year. These new recommendations have been made in response to an anticipated shortage for Aplisol, a purified-protein derivative (PPD) tuberculin antigen approved by the US Food and Drug Administration for

Aculabs is proud to announce that we've been awarded our New York State laboratory permit by the New York State Department of Health. Effective June 6th, 2019, Aculabs can begin onboarding and servicing clients within NYS. Our customer service team will begin getting in touch with those who have expressed interest in acquiring Aculabs' services.

During the week of Monday, May 13th, 2019, Aculabs was happy to welcome representatives from The College of American Pathologists into our doors for the organization's routine yearly inspection. As a clinical laboratory operating across the Mid-Atlantic, Aculabs finds maintaining quality testing that's in-line with all industry-wide accreditation standards extremely important and works to ensure

Lab Week (short for Medical Laboratory Professionals Week) is an annual celebration for medical laboratory professionals, pathologists, and other members of staff who play a vital role in health care and patient advocacy. During Lab Week, organizations and laboratories are encouraged to show signs of appreciation honoring their laboratory crew. This year's celebrations take

During the 1st quarter of 2019, Aculabs has experienced near-record growth. At the end of 2018, a number of laboratories decided to divest themselves from the long term care/assisted living market. Then, in early 2019, Aculabs was asked to take over services for U.S. Labs, a Trident-based company. With the exit of U.S Labs from